4//SEC Filing
Rouan Sarah Kathryn 4
Accession 0000950170-24-117514
CIK 0001607678other
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 7:28 PM ET
Size
8.2 KB
Accession
0000950170-24-117514
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Sale
Common Stock, par value $0.00001 per share
2024-10-25$80.89/sh−11,000$889,790→ 0 total - Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-10-25$4.88/sh+11,000$53,680→ 11,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-25−11,000→ 11,000 totalExercise: $4.88From: 2023-01-03Exp: 2032-01-03→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2024 by the Reporting Person.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001761366
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 7:28 PM ET
- Size
- 8.2 KB